Understanding how certain factors help bacteria translate genetic information
Unraveling context specificity of translation by elucidating the mechanism of action of auxiliary translation factors
This study is looking at how certain antibiotics that target ribosomes work and how helper proteins help bacteria read tough genetic instructions, which could lead to better antibiotics for treating infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11001444 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which ribosome-targeting antibiotics work and how certain auxiliary translation factors (auxTFs) assist in the translation of difficult genetic sequences in bacteria. By using advanced techniques like crosslinking-based ribosome profiling, the study aims to identify the specific sequences that are challenging for ribosomes to translate and the role of auxTFs in overcoming these challenges. The findings could provide insights into bacterial growth under stress and the efficiency of protein synthesis, which are crucial for developing new antibiotics. Patients may benefit indirectly through improved antibiotic therapies that target bacterial infections more effectively.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients suffering from bacterial infections that are resistant to current antibiotic treatments.
Not a fit: Patients with viral infections or non-bacterial diseases are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antibiotics that can better target and treat bacterial infections.
How similar studies have performed: Other research has shown promise in understanding the mechanisms of antibiotic action, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mankin, Alexander S — University of Illinois at Chicago
- Study coordinator: Mankin, Alexander S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.